The biotechnology industry, valued at $1.74 trillion, is facing failure
and criticism due to the high rate of adverse effects and excess deaths
associated with mRNA covid-19 injections.
In an effort to save
themselves, the industry is trying to bypass safety testing and
regulation, and is profiting from lightly regulated areas such as animal
veterinary care and biotechnology food processing, while launching a
fightback through opinion pieces in corporate media....<<<Read More>>>...